Posted in | News | Imaging

BlueOrca Enters OEM Agreement with n-Trance for Biometric Security Devices

BlueOrca Tech has entered in to an OEM agreement with n-Trance Global for their n-Tegrity line of products, including biometric security devices, the n-Integrity software suite and the n-Trance Global secure VOIP device.

n-Tegrity biometric security device

These and other products will marketed under the BlueOrca Tech brand in North America and in selected markets globally.

"We are pleased to enter into a strategic alliance with n-Trance." comments BlueOrca's CEO Gordon Hannigan. "We've done extensive research, and n-Trance's portfolio is the market leader. We are sure that our Enterprise and Government customers will see immediate benefit from using these products." BlueOrca will sell the portfolio direct and through resellers in Australia, Latin America, India and South East Asia.

Daniel Biran, CEO of n-Trance Global states that "the two companies share a common view on securing and using Digital assets. Users need a comprehensive and easy to use solution that they can take anywhere."

BlueOrca is headquartered in Vancouver BC, and specializes in letting its customers secure, carry and connect their digital assets reliably and easily. Its products include OrcaPass software, the BluePOD biometric device and OrcaTalk, the secure way to use corporate VOIP.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.